Bruce Thornton serves as Chief Operating Officer, Secretary of the Company. Mr. Thornton has served as our Chief Operating Officer since April 2020 and serves as our Corporate Secretary. Mr. Thornton served as our Executive Vice President for International and General Manager for U.S. operations from March 2004 to April 2020. He served as Vice President of Operations for Jomed (formerly EndoSonic Corp.) from January 1999 to September 2003, and as Vice President of Manufacturing for Volcano Therapeutics, an international medical device company, following its acquisition of Jomed, until March 2004.
As the Chief Operating Officer und Secretary of Sonoma Pharmaceuticals, the total compensation of Bruce Thornton at Sonoma Pharmaceuticals is $365,374. There are no executives at Sonoma Pharmaceuticals getting paid more.
Bruce Thornton is 56, he's been the Chief Operating Officer und Secretary of Sonoma Pharmaceuticals since 2020. There are 6 older and 4 younger executives at Sonoma Pharmaceuticals. The oldest executive at Sonoma Pharmaceuticals Inc. is Jay Birnbaum, 75, who is the Independent Director.
Bruce's mailing address filed with the SEC is C/O SONOMA PHARMACEUTICALS, INC., 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301.
Over the last 8 years, insiders at Sonoma Pharmaceuticals have traded over $0 worth of Sonoma Pharmaceuticals stock and bought 25,155 units worth $125,359 . The most active insiders traders include Frederick J Sandford, Sharon Barbari und Robert E Miller. On average, Sonoma Pharmaceuticals executives and independent directors trade stock every 27 days with the average trade being worth of $4,840. The most recent stock trade was executed by Robert E Miller on 12 March 2018, trading 2,400 units of SNOA stock currently worth $9,744.
sonoma pharmaceuticals, inc., develops and produces stabilized hypochlorous acid (hocl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the united states and internationally. the company offers epicyn, an antimicrobial facial cleanser; levicyn, a hypochlorous acid (hocl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; celacyn gel, a product indicated to promote healing through the management of new and old scars resulting from surgical procedures and trauma wounds or burns; sebuderm, a product indicated to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis; and ceramax, a lipogrid based skin barrier cream for management of dry itchy skin, minor skin irritations, rashes, and inflammation caused by various skin conditions, as well as loyon for the management of skin scal
Sonoma Pharmaceuticals executives and other stock owners filed with the SEC include: